Masazumi Nagai

Masazumi Nagai's work experience includes:

- Principal Lead Scientist at Northway Biotech since October 2022 (current position)

- Senior Investigator at AB Biosciences since April 2022 (current position)

- Visiting Professor at Iwate Medical University since March 2017 (current position)

- Lecturer, Oral Medicine Infection and Immunity at Harvard School of Dental Medicine since September 2019 (current position)

- Principal Scientist at Northway Biotech from July 2020 to March 2022

- Sr Scientist at QLB Biotherapeutics from September 2018 to January 2020

- Scientist at Abpro Therapeutics from October 2016 to September 2018

- Principal Scientist at Synta Pharmaceuticals from October 2003 to June 2015

Masazumi Nagai's education history includes attending Harvard School of Dental Medicine, but no specific degree or field of study is provided. In 1975, Nagai attended Iwate Medical University, where they obtained a Doctor of Philosophy (Ph.D.) with a focus on Dentistry/Biochemistry. In 1981, Nagai obtained a certification as a Dentist/Orthodontist.